All Articles

Rapid Medical's new TIGERTRIEVER 25 gains FDA clearance, offering doctors unprecedented real-time control to remove large, complex clots in stroke patients.

A major consolidation in telecom sees the O-RAN Software Community join LF Networking, creating a unified, end-to-end open source 5G platform.

With Teyana Taylor at the helm, ESSENCE adds Mara Brock Akil, Nikole Hannah-Jones, and Nina Compton to build a deeper, more immersive 2026 festival.

In under three years, Tema ETFs has attracted billions, largely from institutions, by combining top-performing active funds with unique access to SpaceX.

With 60% of searches ending without a click, a new platform aims to measure what matters: a brand's visibility within AI-generated answers.

An FDA-approved system lets surgeons see residual cancer in real-time during lumpectomies, offering new hope for avoiding the dreaded second surgery.

Positioning Universal's solar trackers are now on Geotab's instant-buy platform, a move set to streamline operations for fleets in construction and logistics.

Exclaimer's new Workday integration automates email signatures from HR data, slashing IT workload and ending the risk of outdated employee information.

A Manhattan skyscraper is getting super-insulating windows to dodge climate fines, slash energy use by 20%, and boost tenant comfort. Here’s how.

The University of Florida unveils its new Mondo Super X 720 track, a high-tech marvel fueling record hopes at the prestigious Tom Jones Memorial Invitational.

The AI platform, backed by EPIC Ventures, uses proprietary buyer interviews to turn research into revenue for clients like Intel, Verizon, and CDW.

With a new CEO and a bold crypto focus, Focus Markets is rebranding to carve its own path, distinct from its sister company Eightcap. What's the play?

Panasonic's new TOUGHBOOK 56 brings AI, Wi-Fi 7, and unmatched modularity to the most demanding field environments, setting a new standard for rugged computing.

CirTran reports a 141% revenue jump and narrowing losses, but a closer look reveals one-time gains and significant underlying financial risks.

New research reveals staggering suicide rates in construction, mining, and fishing, linking them to a culture of stoicism and practical barriers to care.

San Diego's Blacksmith Medicines will present promising data on its FEN1 inhibitor, a new drug targeting a notoriously difficult class of enzymes.

Following a $295M exploit, Solana DEX Drift Protocol gets a lifeline from Tether, plotting a relaunch that will reshape the ecosystem's stablecoin landscape.

A new survey shows nearly half of employers are considering international drug sourcing, a legally murky strategy, as cost control dethrones talent retention.

GC Biopharma's new data on ALYGLO's purity profile could set a new standard for IVIG therapies, impacting patient safety in a rapidly growing market.

The chipmaker is expanding beyond consumer electronics, launching a new IC family to power the next generation of high-precision industrial scanners and machine vision.